Effects of CDC42 on the proliferation and invasion of gastric cancer cells

被引:30
|
作者
Du, Dong-Shu [1 ]
Yang, Xiao-Zhong [2 ]
Wang, Qiong [2 ]
Dai, Wei-Jie [2 ]
Kuai, Wen-Xia [2 ]
Liu, Ye-Liu [3 ]
Chu, Dechang [4 ]
Tang, Xiao-Jun [3 ]
机构
[1] Shanghai Univ, Coll Life Sci, Shanghai Key Lab Bioenergy Crops, Lab Neuropharmacol & Neurotoxicol, Shanghai 200444, Peoples R China
[2] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Digest, Huaian 223300, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Gastrointestinal Surg, Huaian 223300, Jiangsu, Peoples R China
[4] Heze Univ, Dept Life Sci, Heze 274015, Shandong, Peoples R China
关键词
CDC42; gastric cancer; proliferation; migration; cell cycle; invasion; EXPRESSION; OVEREXPRESSION; GTPASES;
D O I
10.3892/mmr.2015.4523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell division cycle 42 (CDC42), which is a member of the Rho GTPase family, has been reported to regulate the metastasis of various human cancer cells; however, the role of CDC42 in gastric cancer (GC) remains unclear. The present study aimed to investigate the effects of CDC42 on the proliferation, migration and invasion of GC. Furthermore, the molecular mechanisms underlying the effects of CDC42 on GC were explored. The expression levels of CDC42 in the AGS and SGC7901 human GC cell lines were reduced by RNA interference. Knockdown of CDC42 significantly inhibited the proliferation of AGS and SGC7901 cells, and it was suggested that this inhibitory process may be due to cell cycle arrest at G1/S phase and downregulation of cyclin A, cyclin D1, cyclin E and proliferating cell nuclear antigen. Furthermore, knockdown of CDC42 markedly inhibited the migration and invasion of GC cells, and suppressed the expression of matrix metalloproteinase 9. These results indicated that CDC42 is a key regulator involved in regulating the proliferation, migration and invasion of GC, and it may be considered a potential therapeutic target in GC.
引用
收藏
页码:550 / 554
页数:5
相关论文
共 50 条
  • [1] The role of Cdc42 in cancer cell perineural invasion
    Chernichenko, Natalya
    Omelchenko, Tatiana
    Deborde, Sylvie
    Bakst, Richard
    He, Shuangba
    Chen, Chun-Hao
    Hall, Alan
    Wong, Richard J.
    [J]. CANCER RESEARCH, 2012, 72
  • [2] Cdc42 Mediates Cancer Cell Chemotaxis in Perineural Invasion
    Chernichenko, Natalya
    Omelchenko, Tatiana
    Deborde, Sylvie
    Bakst, Richard L.
    He, Shizhi
    Chen, Chun-Hao
    Gusain, Laxmi
    Vakiani, Efsevia
    Katabi, Nora
    Hall, Alan
    Wong, Richard J.
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (06) : 913 - 925
  • [3] Activation of Rho GTPase Cdc42 promotes adhesion and invasion in colorectal cancer cells
    Gao, Lei
    Bai, Lan
    Nan, Qing-zhen
    [J]. MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2013, 19 : 201 - 207
  • [4] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration
    Ye, Hongnan
    Zhang, Youyi
    Geng, Li
    Li, Zijian
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (02) : 757 - 763
  • [5] miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42
    Li, Yuefeng
    Zhu, Xiaolan
    Xu, Wenlin
    Wang, Dongqing
    Yan, Jinchuan
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (03) : 560 - 565
  • [6] Targeting Cdc42 in cancer
    Arias-Romero, Luis E.
    Chernoff, Jonathan
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (11) : 1263 - 1273
  • [7] Cdc42 in oncogenic transformation, invasion, and tumorigenesis
    Stengel, Kristy
    Zheng, Yi
    [J]. CELLULAR SIGNALLING, 2011, 23 (09) : 1415 - 1423
  • [8] Cdc42 helps cancer cells make their exit
    Short, Ben
    [J]. JOURNAL OF CELL BIOLOGY, 2012, 199 (04): : 567 - 567
  • [9] Invasion of breast cancer cells into collagen matrix requires TGF-α and Cdc42 signaling
    Kikuchi, Keiji
    Li, Xiaohan
    Zheng, Yang
    Takano, Yasuo
    [J]. FEBS LETTERS, 2011, 585 (02) : 286 - 290
  • [10] MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
    Gu, Gengshi
    Wang, Li
    Zhang, Junchen
    Wang, Hao
    Tan, Tan
    Zhang, Guangning
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 4075 - 4085